))
PhageLine #5: The LNT103 engineered endolysin for Gram-negative pathogens
Manage episode 468336940 series 3648800
Content provided by Planomicrobium massiliensis. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Planomicrobium massiliensis or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Welcome to PhageLine. This week we will focus on using specific phage proteins called endolysins instead of whole phages to fight bacteria by discussing the in vitro and in vivo efficacy of an engineered endolysin targeting Gram-negative pathogens. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
32 episodes
Share
